KDR and neoplasm: In tumor-bearing mice and metastatic colorectal cancer patients, VEGF-A can directly activate Treg cell proliferation in a VEGFR-2-dependent manner [16], as well as contributing to tumor-associated macrophage (TAM) development, by inducing the recruitment of monocytes/macrophages to the tumor.